ArticleNature reviews. Materials2026
Can nanozymes achieve more than enzymes?
Article in Nature reviews. Materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Resolving the issue of non-specific substrate oxidation in nanozyme-assisted colorimetric assays.Analytical and bioanalytical chemistry · 2026Article
- Advances in ultrasound-mediated nanozyme systems in therapeutic applications.Ultrasonics sonochemistry · 2026Review
- Nanozyme-Mediated Cellular and Microenvironmental Metabolic Reprogramming for Boosting Cancer Immunotherapy.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Living Inorganic Nanomaterials: Design, Preparation, and Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Chemotactic Gold Nanozyme-Powered Flasklike Pentosan Nanobots for Tumor-Specific Drug Delivery.Advanced healthcare materials · 2026Article
- Noble metal nanozymes: synthesis, mechanism, activity regulation and detection applications.Mikrochimica acta · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Nanozymes have progressed from simple enzyme mimics to a versatile class of artificial catalysts that expand functionality beyond the reach of natural enzymes. Their unique compositional and structural properties confer exceptional versatility in catalysis, enabling catalytic function in non-biological environments, the promotion of non-natural reactions, and the integration of multiple catalytic activities within a single nanostructure. By exploiting nanoscale control over physicochemical parameters, and/or emulating enzyme architectures, nanozymes can achieve finely tunable activity and selectivity. Their ability to undergo facile surface functionalization and provide electrical connectivity further enhances their performance in complex systems. Collectively, these attributes extend catalysis beyond the constraints of natural enzymes, driving innovations in an array of different fields including biomedicine, agriculture, environmental remediation, and energy conversion. Looking forward, rationally designed nanozymes have the potential to redefine the field of catalysis, evolving from biomimetic surrogates into transformative materials that rival, and ultimately surpass, the capabilities of natural enzymes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.